Erica Finolezzi
About
In The Last Decade
Erica Finolezzi
21 papers receiving 424 citations
Peers
Comparison fields: 5 of 48
- Pathology and Forensic Medicine 210
- Neurology 146
- Molecular Biology 111
- Hematology 106
- Oncology 103
Countries citing papers authored by Erica Finolezzi
This map shows the geographic impact of Erica Finolezzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erica Finolezzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erica Finolezzi more than expected).
Fields of papers citing papers by Erica Finolezzi
This network shows the impact of papers produced by Erica Finolezzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erica Finolezzi. The network helps show where Erica Finolezzi may publish in the future.
Co-authorship network of co-authors of Erica Finolezzi
This figure shows the co-authorship network connecting the top 25 collaborators of Erica Finolezzi. A scholar is included among the top collaborators of Erica Finolezzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erica Finolezzi. Erica Finolezzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 9 | |
| 3 | 106 | |
| 4 | 4 | |
| 5 | 3 | |
| 6 | INVASIVE CANDIDA INFECTIONS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES AND HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: CURRENT EPIDEMIOLOGY AND THERAPEUTIC OPTIONS. | 1 |
| 7 | 13 | |
| 8 | 14 | |
| 9 | 1 | |
| 10 | 10 | |
| 11 | 29 | |
| 12 | 8 | |
| 13 | 102 | |
| 14 | The role of BCR/ABL isoforms in the presentation and outcome of patients with Philadelphia-positive acute lymphoblastic leukemia: a seven-year update of the GIMEMA 0496 trial. | 33 |
| 15 | [Therapeutic advances in neoplastic hematology: target therapy anti-CD33]. | 1 |
| 16 | 3 | |
| 17 | 0 | |
| 18 | 3 | |
| 19 | Relevance of CD79a expression for T-cell lineage attribution in CD7+/CD3- acute lymphoblastic leukemia. | 1 |
| 20 | The antineoplastic treatment in the elderly. | 3 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.